ArticleIndian journal of pediatrics2026
Assessing the Role of Delta Copeptin in the Evaluation of SIAD and CSW.
Article in Indian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe current diagnostic methods for syndrome of inappropriate antidiuresis (SIAD) and cerebral salt wasting (CSW), are imprecise. Gold standard radioisotope methodologies are currently confined to research settings. Therefore, this study evaluated whether the change in copeptin levels could be an early diagnostic tool.
methodsA study was conducted on hyponatremic (≤ 130 meq/L) children. Subjects with endocrine disorders, systemic diseases, diarrhea, and shock were excluded. At baseline, copeptin and fractional excretion of uric acid (FEUA) were measured. Subjects then received maintenance 0.9% normal saline (NS) for six hours. Fluid deficits and polyuria were managed with fluid replacement, while symptomatic hyponatremia was treated with 3% NS. After six hours, copeptin and NT-proBNP were reassessed. Subjects were monitored until serum sodium normalized to differentiate CSW from SIAD using FEUA levels.
resultsThe present study included 15 subjects (66.67% had tubercular meningitis; 11 SIAD and four CSW). Copeptin levels showed no correlation with the degree of hyponatremia (r = 0.126). However, delta copeptin was significantly different and showed a decrease in the SIAD group [-16.43 (-39.07, -4.57) vs. 7.94 (-2.30, 29.80) pmol/L, p = 0.024]. A cut-off value for delta copeptin of -9.62 pmol/L [0.864 (0.665-1.00)], yielded a sensitivity of 100% and a specificity of 63.6% for CSW. The utility of other biomarkers (delta NT proBNP, copeptin/urine sodium and serum uric acid) could not be established.
conclusionsThe present study demonstrates the role of delta copeptin as a potential diagnostic biomarker in the evaluation of SIAD vs. CSW.
Indexed as
Identifiers
41563654What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.